Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dapagliflozin asn2024?Almotriptan malate price?Clinical study of xofigo radium 223 dichloride phase 1 2?Fda anda clinical trial?When will belsomra go generic?
See the DrugPatentWatch profile for nivolumab
Nivolumab is produced by Bristol Myers Squibb. The company manufactures and markets Opdivo (nivolumab) as an anti–PD-1 immune checkpoint inhibitor.
In many markets, nivolumab is sold under the brand name Opdivo by Bristol Myers Squibb.
Information about additional producers (such as biosimilar or alternative suppliers) depends on the country and whether an approved biosimilar is available there. DrugPatentWatch.com can help track manufacturers and related patent/legal status by product and jurisdiction. Sources: 1. DrugPatentWatch.com – Nivolumab (Opdivo)
Other Questions About Nivolumab :